Hydrogel-based Drug Delivery System Market

Table of Content

1. Executive Summary

    1.1. Global Hydrogel-based Drug Delivery System Market Snapshot, 2024 and 2031

    1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn

    1.3. Key Market Trends

    1.4. Future Market Projections

    1.5. Premium Market Insights

    1.6. Industry Developments and Key Market Events 

    1.7. PMR Analysis and Recommendations

2. Market Overview

    2.1. Market Scope and Definition

    2.2. Market Dynamics

    2.2.1. Drivers

    2.2.2. Restraints

    2.2.3. Opportunity

    2.2.4. Challenges

    2.2.5. Key Trends

    2.3. Macro-Economic Factors

        2.3.1. Global Sectorial Outlook

        2.3.2. Global GDP Growth Outlook

        2.3.3. Global Healthcare Spending Outlook

    2.4. COVID-19 Impact Analysis

    2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights 

    3.1. Epidemiology - Prevalence and Incidence of Target Diseases 

    3.2. Regulatory Landscape

    3.3. Value Chain Analysis

    3.4. Key Deals and Mergers

    3.5. PESTLE Analysis

    3.6. Porter's Five Force Analysis

4. Global Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

    4.1. Key Highlights

        4.1.1. Market Size (US$ Mn) and Y-o-Y Growth

        4.1.2. Absolute $ Opportunity

    4.2. Market Size (US$ Mn) Analysis and Forecast

        4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022

        4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031

    4.3. Global Hydrogel-based Drug Delivery System Market Outlook: Polymer Origin

        4.3.1. Introduction / Key Findings

        4.3.2. Historical Market Size (US$ Bn) Analysis, By Polymer Origin, 2018 - 2022

        4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031

            4.3.3.1. Natural

            4.3.3.2. Synthetic

            4.3.3.3. Hybrid

    4.4. Market Attractiveness Analysis: Polymer Origin

    4.5. Global Hydrogel-based Drug Delivery System Market Outlook: Delivery Route

        4.5.1. Introduction / Key Findings

        4.5.2. Historical Market Size (US$ Mn) Analysis, By Delivery Route, 2018 - 2022

        4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031

            4.5.3.1. Subcutaneous

            4.5.3.2. Oral Cavity

            4.5.3.3. Ocular

            4.5.3.4. Topical

            4.5.3.5. Others

    4.6. Market Attractiveness Analysis: Delivery Route

    4.7. Global Hydrogel-based Drug Delivery System Market Outlook: Distribution Channel

        4.7.1. Introduction / Key Findings

        4.7.2. Historical Market Size (US$ Mn) Analysis, By  Distribution Channel, 2018 - 2022

        4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By  Distribution Channel, 2023 - 2031

            4.7.3.1. Hospitals

            4.7.3.2. Specialty Clinics

            4.7.3.3. Diagnostic Centres

            4.7.3.4. Research and Academic Institutes

    4.8. Market Attractiveness Analysis: Distribution Channel

5. Global Hydrogel-based Drug Delivery System Market Outlook: Region

    5.1. Key Highlights

    5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2018 - 2022

    5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2023 - 2031

        5.3.1. North America

        5.3.2. Europe

        5.3.3. East Asia

        5.3.4. South Asia and Oceania

        5.3.5. Latin America

        5.3.6. Middle East & Africa

    5.4. Market Attractiveness Analysis: Region

6. North America Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031) 

    6.1. Key Highlights

    6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022

        6.2.1. By Country

        6.2.2. By Polymer Origin

        6.2.3. By Delivery Route

        6.2.4. By Distribution Channel

    6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

        6.3.1. U.S.

        6.3.2. Canada

    6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031

        6.4.1. Natural

        6.4.2. Synthetic

        6.4.3. Hybrid

    6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031

        6.5.1. Subcutaneous

        6.5.2. Oral Cavity

        6.5.3. Ocular

        6.5.4. Topical

        6.5.5. Others

    6.6. Current Market Size (US$ Mn) Analysis and Forecast, By  Distribution Channel, 2023 - 2031

        6.6.1. Hospitals

        6.6.2. Specialty Clinics

        6.6.3. Retail Pharmacy Chains

        6.6.4. Drug Stores

        6.6.5. Online Sales Channel

    6.7. Market Attractiveness Analysis

7. Europe Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

    7.1. Key Highlights

    7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022

        7.2.1. By Country

        7.2.2. By Polymer Origin

        7.2.3. By Delivery Route

        7.2.4. By  Distribution Channel 

    7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

        7.3.1. Germany

        7.3.2. France

        7.3.3. U.K.

        7.3.4. Italy

        7.3.5. Spain

        7.3.6. Russia

        7.3.7. Türkiye

        7.3.8. Rest of Europe

    7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031

        7.4.1. Natural

        7.4.2. Synthetic

        7.4.3. Hybrid

    7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031

        7.5.1. Subcutaneous

        7.5.2. Oral Cavity

        7.5.3. Ocular

        7.5.4. Topical

        7.5.5. Others

    7.6. Current Market Size (US$ Mn) Analysis and Forecast, By  Distribution Channel, 2023 - 2031

        7.6.1. Hospitals

        7.6.2. Specialty Clinics

        7.6.3. Retail Pharmacy Chains

        7.6.4. Drug Stores

        7.6.5. Online Sales Channel

    7.7. Market Attractiveness Analysis

8. East Asia Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

    8.1. Key Highlights

    8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022

        8.2.1. By Country

        8.2.2. By Polymer Origin

        8.2.3. By Delivery Route

        8.2.4. By  Distribution Channel 

    8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

        8.3.1. China

        8.3.2. Japan

        8.3.3. South Korea

    8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031

        8.4.1. Natural

        8.4.2. Synthetic

        8.4.3. Hybrid

    8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031

        8.5.1. Subcutaneous

        8.5.2. Oral Cavity

        8.5.3. Ocular

        8.5.4. Topical

        8.5.5. Others

    8.6. Current Market Size (US$ Mn) Analysis and Forecast, By  Distribution Channel, 2023 - 2031

        8.6.1. Hospitals

        8.6.2. Specialty Clinics

        8.6.3. Retail Pharmacy Chains

        8.6.4. Drug Stores

        8.6.5. Online Sales Channel

    8.7. Market Attractiveness Analysis

9. South Asia & Oceania Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

    9.1. Key Highlights

    9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022

        9.2.1. By Country

        9.2.2. By Polymer Origin

        9.2.3. By Delivery Route

        9.2.4. By  Distribution Channel 

    9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

        9.3.1. India

        9.3.2. Southeast Asia

        9.3.3. ANZ

        9.3.4. Rest of South Asia & Oceania

    9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031

        9.4.1. Natural

        9.4.2. Synthetic

        9.4.3. Hybrid

    9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031

        9.5.1. Subcutaneous

        9.5.2. Oral Cavity

        9.5.3. Ocular

        9.5.4. Topical

        9.5.5. Others

    9.6. Current Market Size (US$ Mn) Analysis and Forecast, By  Distribution Channel, 2023 - 2031

        9.6.1. Hospitals

        9.6.2. Specialty Clinics

        9.6.3. Retail Pharmacy Chains

        9.6.4. Drug Stores

        9.6.5. Online Sales Channel

    9.7. Market Attractiveness Analysis

10. Latin America Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

    10.1. Key Highlights

    10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022

        10.2.1. By Country

        10.2.2. By Polymer Origin

        10.2.3. By Delivery Route

        10.2.4. By  Distribution Channel 

    10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

        10.3.1. Brazil

        10.3.2. Mexico

        10.3.3. Rest of Latin America

    10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031

        10.4.1. Natural

        10.4.2. Synthetic

        10.4.3. Hybrid

    10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031

        10.5.1. Subcutaneous

        10.5.2. Oral Cavity

        10.5.3. Ocular

        10.5.4. Topical

        10.5.5. Others

    10.6. Current Market Size (US$ Mn) Analysis and Forecast, By  Distribution Channel, 2023 - 2031

        10.6.1. Hospitals

        10.6.2. Specialty Clinics

        10.6.3. Retail Pharmacy Chains

        10.6.4. Drug Stores

        10.6.5. Online Sales Channel

    10.7. Market Attractiveness Analysis

11. Middle East & Africa Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

    11.1. Key Highlights

    11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022

        11.2.1. By Country

        11.2.2. By Polymer Origin

        11.2.3. By Delivery Route

        11.2.4. By  Distribution Channel 

    11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

        11.3.1. GCC Countries

        11.3.2. Egypt

        11.3.3. South Africa

        11.3.4. Northern Africa

        11.3.5. Rest of Middle East & Africa

    11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031

        11.4.1. Natural

        11.4.2. Synthetic

        11.4.3. Hybrid

    11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031

        11.5.1. Subcutaneous

        11.5.2. Oral Cavity

        11.5.3. Ocular

        11.5.4. Topical

        11.5.5. Others

    11.6. Current Market Size (US$ Mn) Analysis and Forecast, By  Distribution Channel, 2023 - 2031

        11.6.1. Hospitals

        11.6.2. Specialty Clinics

        11.6.3. Retail Pharmacy Chains

        11.6.4. Drug Stores

        11.6.5. Online Sales Channel

    11.7. Market Attractiveness Analysis

12. Competition Landscape

    12.1. Market Share Analysis, 2023

    12.2. Market Structure

        12.2.1. Competition Intensity Mapping By Market 

        12.2.2. Competition Dashboard

    12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)

        12.3.1. GALDERMA 

            12.3.1.1. Overview

            12.3.1.2. Segments and Products

            12.3.1.3. Key Financials

            12.3.1.4. Market Developments

            12.3.1.5. Market Strategy

        12.3.2. Blairex Laboratories, Inc.

            12.3.2.1. Overview

            12.3.2.2. Segments and Products

            12.3.2.3. Key Financials

            12.3.2.4. Market Developments

            12.3.2.5. Market Strategy

        12.3.3. Johnson & Johnson

            12.3.3.1. Overview

            12.3.3.2. Segments and Products

            12.3.3.3. Key Financials

            12.3.3.4. Market Developments

            12.3.3.5. Market Strategy

        12.3.4. Bausch and Lomb

            12.3.4.1. Overview

            12.3.4.2. Segments and Products

            12.3.4.3. Key Financials

            12.3.4.4. Market Developments

            12.3.4.5. Market Strategy

        12.3.5. Medtronic

            12.3.5.1. Overview

            12.3.5.2. Segments and Products

            12.3.5.3. Key Financials

            12.3.5.4. Market Developments

            12.3.5.5. Market Strategy

        12.3.6. Ocular Therapeutix, Inc.

            12.3.6.1. Overview

            12.3.6.2. Segments and Products

            12.3.6.3. Key Financials

            12.3.6.4. Market Developments

            12.3.6.5. Market Strategy

        12.3.7. Ferring B.V.

            12.3.7.1. Overview

            12.3.7.2. Segments and Products

            12.3.7.3. Key Financials

            12.3.7.4. Market Developments

            12.3.7.5. Market Strategy

        12.3.8. Endo International plc

            12.3.8.1. Overview

            12.3.8.2. Segments and Products

            12.3.8.3. Key Financials

            12.3.8.4. Market Developments

            12.3.8.5. Market Strategy

        12.3.9. Akorn, Incorporated

            12.3.9.1. Overview

            12.3.9.2. Segments and Products

            12.3.9.3. Key Financials

            12.3.9.4. Market Developments

            12.3.9.5. Market Strategy

        12.3.10. Tolmar Pharmaceuticals, Inc

            12.3.10.1. Overview

            12.3.10.2. Segments and Products

            12.3.10.3. Key Financials

            12.3.10.4. Market Developments

            12.3.10.5. Market Strategy

13. Appendix

    13.1. Research Methodology

    13.2. Research Assumptions

    13.3. Acronyms and Abbreviations

List Of Table

- List Of Chart -